Hims & Hers Health (HIMS) Non-Current Deffered Revenue (2019 - 2021)
Hims & Hers Health (HIMS) posted Non-Current Deffered Revenue of $384000.0 for Q1 2021, up 0.79% sequentially from $381000.0 in Q4 2020, and down 94.55% YoY from $7.0 million in Q1 2020.
Hims & Hers Health (HIMS) Non-Current Deffered Revenue (2019 - 2021) Analysis & Trends
Hims & Hers Health has reported Non-Current Deffered Revenue for 3 years, with the latest figure at $384000.0 in Q1 2021.
- Quarterly Non-Current Deffered Revenue fell 94.55% year-over-year to $384000.0 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $384000.0 (down 94.55% YoY) and the FY2020 annual result came in at $381000.0, down 94.59% from the prior year.
- Non-Current Deffered Revenue improved to $384000.0 in Q1 2021 per HIMS's latest filing, from $381000.0 in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $7.0 million in Q3 2019 and troughed at $381000.0 in Q4 2020.
- A 3-year average of $5.1 million and a median of $7.0 million in 2019 frame the typical range for Non-Current Deffered Revenue.
- The widest YoY moves for Non-Current Deffered Revenue: up 0.0% in 2020, down 94.59% in 2020.
- Over 3 years, Non-Current Deffered Revenue stood at $7.0 million in 2019, then plunged by 94.59% to $381000.0 in 2020, then climbed by 0.79% to $384000.0 in 2021.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $384000.0, $381000.0, and $7.0 million for Q1 2021, Q4 2020, and Q3 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 384,000.00 |
| Dec 31, 2020 | 381,000.00 |
| Sep 30, 2020 | 7.04 Mn |
| Jun 30, 2020 | 7.04 Mn |
| Mar 31, 2020 | 7.04 Mn |
| Dec 31, 2019 | 7.04 Mn |
| Sep 30, 2019 | 7.04 Mn |